Vascular heterogeneity of tight junction Claudins guides organotropic metastasis
- 17 September 2024
- journal article
- research article
- Published by Springer Nature in Nature Cancer
- Vol. 5 (9) , 1371-1389
Abstract
Carcinomas are associated with metastasis to specific organs while sparing others. Breast cancer presents with lung metastasis but rarely kidney metastasis. Using this difference as an example, we queried the mechanism(s) behind the proclivity for organ-specific metastasis. We used spontaneous and implant models of metastatic mammary carcinoma coupled with inflammatory tissue fibrosis, single-cell sequencing analyses and functional studies to unravel the causal determinants of organ-specific metastasis. Here we show that lung metastasis is facilitated by angiopoietin 2 (Ang2)-mediated suppression of lung-specific endothelial tight junction protein Claudin 5, which is augmented by the inflammatory fibrotic microenvironment and prevented by anti-Ang2 blocking antibodies, while kidney metastasis is prevented by non-Ang2-responsive Claudins 2 and 10. Suppression of Claudins 2 and 10 was sufficient to induce the emergence of kidney metastasis. This study illustrates the influence of organ-specific vascular heterogeneity in determining organotropic metastasis, independent of cancer cell-intrinsic mechanisms.Keywords
Funding Information
- U.S. Department of Health & Human Services | NIH | National Cancer Institute (R01CA252729, P30CA016672)
- Cancer Prevention and Research Institute of Texas (RP200612)
This publication has 62 references indexed in Scilit:
- Epigenetic Reprogramming of Cancer-Associated Fibroblasts Deregulates Glucose Metabolism and Facilitates Progression of Breast CancerCell Reports, 2020
- Fibrosis and cancer: A strained relationshipBiochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2020
- Single-Cell Transcriptome Atlas of Murine Endothelial CellsCell, 2020
- Normalization of Tumor Vessels by Tie2 Activation and Ang2 Inhibition Enhances Drug Delivery and Produces a Favorable Tumor MicroenvironmentCancer Cell, 2017
- Targeting Vascular Pericytes in Hypoxic Tumors Increases Lung Metastasis via Angiopoietin-2Cell Reports, 2015
- Postsurgical Adjuvant Tumor Therapy by Combining Anti-Angiopoietin-2 and Metronomic Chemotherapy Limits Metastatic GrowthCancer Cell, 2014
- Angiopoietin‐2 mediates blood–brain barrier impairment and colonization of triple‐negative breast cancer cells in brainThe Journal of Pathology, 2013
- A Role for Angiopoietin-2 in Organ-Specific MetastasisCell Reports, 2013
- Pericyte Depletion Results in Hypoxia-Associated Epithelial-to-Mesenchymal Transition and Metastasis Mediated by Met Signaling PathwayCancer Cell, 2012
- Angiopoietin‐2 expression in breast cancer correlates with lymph node invasion and short survivalInternational Journal of Cancer, 2002